Organon (OGN) Shares Outstanding (Diluted Average) (2020 - 2026)

Organon's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $262.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 0.73% year-over-year to $262.9 million; the TTM figure through Mar 2026 stood at $262.9 million (up 0.73% YoY), while the FY2025 annual figure was $260.8 million, up 0.62% from the prior year.
• Shares Outstanding (Diluted Average) was $262.9 million for Q1 2026 at Organon, up from $260.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $262.9 million in Q1 2026 to a low of $255.1 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $258.1 million across 5 years, with a median of $258.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) rose 1.33% in 2024, then advanced 0.33% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $255.2 million in 2022, then climbed by 0.43% to $256.3 million in 2023, then advanced by 1.12% to $259.2 million in 2024, then gained by 0.62% to $260.8 million in 2025, then grew by 0.82% to $262.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $262.9 million (Q1 2026), $260.8 million (Q4 2025), and $260.6 million (Q3 2025), per Business Quant data.